Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:ATCCode |
gptkb:J01FA01
|
| gptkbp:CASNumber |
114-07-8
|
| gptkbp:chemical_compound |
C37H67NO13
|
| gptkbp:component |
Erythromycin complex
|
| gptkbp:drugClass |
antibacterial
|
| gptkbp:hasSMILES |
CC[C@H]1C(C(=O)O[C@H](C)[C@@H](O)[C@H](C)O[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@H](C)O2)[C@H](O)[C@H](O)[C@H](C)O1
|
| gptkbp:hasUNII |
1Q7Z1K4Q1K
|
| https://www.w3.org/2000/01/rdf-schema#label |
Erythromycin B
|
| gptkbp:isLessCommonThan |
gptkb:Erythromycin_A
|
| gptkbp:IUPACName |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione
|
| gptkbp:mechanismOfAction |
inhibits bacterial protein synthesis
|
| gptkbp:meltingPoint |
135-140°C
|
| gptkbp:molecularWeight |
733.93 g/mol
|
| gptkbp:producedBy |
gptkb:Streptomyces_erythreus
|
| gptkbp:PubChem_CID |
6437576
|
| gptkbp:relatedTo |
gptkb:Erythromycin
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
allergic reaction
gastrointestinal upset |
| gptkbp:bfsParent |
gptkb:Erythromycin
|
| gptkbp:bfsLayer |
5
|